Carolin Knorr-Hendreich is owner of KNORR Health Strategy, a market access management & consultancy company founded 2006. She advises clinical-stage companies regarding European market access processes and pricing and supports the launch of new therapeutic agents. Additionally, Carolin offers her services as interim manager to pharmaceutical and biotech companies and consultancies (director level).

Customers profit from her in-depth knowledge in strategic development of market access initiatives and their operational implementation. Carolin has proven competence in multiple indications, particularly in rare diseases, oncology, immunology, neurology and genetic disorders. She has a sound expertise in preparation of HTA processes throughout Europe as well as in preparation and execution of effective negotiation and contracting strategies with payers.

Carolin is a Political Scientist (Master of Arts, University of Heidelberg) and holds a postgraduate degree in Market Access Management (EBS University of Business and Law, EBS European Business School, Wiesbaden/Oestrich-Winkel). As a plus, she is a certified Qualified Negotiator®(Schranner Negotiation Institute, Zurich).